Back to search

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

Data up to Jan 2025

Published2005
Citations82
References29

Total Citations Per Year

Abstract

References (29)

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1999 • 5,053 citations

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

1999 • 4,963 citations

The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure

1996 • 4,580 citations

Effect of Carvedilol on Survival in Severe Chronic Heart Failure

2001 • 3,011 citations

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

2003 • 1,869 citations

Effect of carvedilol on survival in severe chronic heart failure

2001 • 1,630 citations

Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure

2000 • 1,365 citations

Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure

2002 • 1,287 citations

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy

1993 • 1,218 citations

Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure

1996 • 1,182 citations

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.

1994 • 1,051 citations

A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure

2001 • 973 citations

Cardiovascular protection and blood pressure reduction: a meta-analysis

2001 • 963 citations

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

1975 • 835 citations

Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial

2001 • 520 citations

Xamoterol in severe heart failure

1990 • 449 citations

PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE

1979 • 415 citations

β-Blocker Therapy in Heart Failure

2002 • 312 citations

Mode of death in chronic heart failure: A request and proposition for more accurate classification

1996 • 209 citations

LUNG CANCER AND SMOKING.

1964 • 208 citations

The Cardiac Insufficiency Bisoprolol Study II

1999 • 122 citations

Bisoprolol for the treatment of chronic heart failure: A meta-analysis on individual data of two placebo-controlled studies—CIBIS and CIBIS II

2002 • 96 citations

Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET

2002 • 90 citations

Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease

2000 • 89 citations

Endothelial Adrenoceptors

2001 • 74 citations

Do β-blockers prolong survival in heart failure only by inhibiting the β1-receptor? A perspective on the results of the COMET trial

2003 • 65 citations

Classification of Sudden and Arrhythmic Death

1997 • 43 citations

3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial

1998 • 40 citations

Effects Of Digoxin, Furosemide, Enalaprilat And Metoprolol On Endothelial Function In Young Normotensive Subjects

2001 • 15 citations

Cited By (0)

Loading...